Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SZSE:002323
SZSE:002323Electrical

Asian Market Gems: Penny Stocks To Watch In November 2025

As the Asian markets navigate a landscape shaped by global economic shifts, including a temporary U.S.-China trade truce and steady interest rates in major economies like Japan, investors are keenly observing how these developments influence regional equities. Penny stocks, often associated with smaller or emerging companies, continue to attract attention for their potential to offer growth opportunities at accessible price points. Despite their vintage label, these stocks can present...
NYSE:SMRT
NYSE:SMRTElectronic

SmartRent (SMRT): Losses Narrow 5.7% Annually, But Profitability Remains Out of Reach

SmartRent (SMRT) remains unprofitable, but it has managed to reduce its losses at an average rate of 5.7% per year over the past five years. The stock trades at $1.40, trading above its estimated fair value of $0.52, and it posts a Price-to-Sales Ratio of 1.7x, which is lower than both its peer average of 5.4x and the US Electronic industry average of 2.6x. While profitability is still out of reach and net profit margins have not shown improvement, investors may look to narrowing losses and...
NYSE:TREX
NYSE:TREXBuilding

Trex (TREX) Profit Margin Decline Challenges Bullish Valuation Narrative Despite Forecasted Earnings Growth

Trex Company (TREX) is forecast to grow earnings by around 7% and revenues by 6.8% annually, both trailing the broader US market’s projected growth rates of 16% and 10.5%, respectively. The company’s net profit margin now stands at 16.5%, down from 21.1% last year. It has averaged annual earnings growth of 3% over the past five years and currently has no notable risks flagged. With the stock trading below estimated fair value and profit and revenue growth expectations still intact, investors...
NasdaqGS:LAB
NasdaqGS:LABLife Sciences

Standard BioTools (LAB): Profitability Challenges Persist Despite Attractive Price-to-Sales Ratio

Standard BioTools (LAB) remains unprofitable, with net losses deepening at an average annual rate of 17.3% over the last five years. Revenue is forecast to grow by just 2.5% per year, which trails the broader US market’s average of 10.5%. Despite a comparatively attractive Price-to-Sales ratio of 2.5x versus industry peers, there is no sign of positive net profit margin or margin improvement. The company is expected to continue booking losses for at least the next three years. See our full...
NasdaqCM:OSS
NasdaqCM:OSSTech

One Stop Systems (OSS): Losses Worsen Despite 15.1% Revenue Growth, Challenging Bull Narratives

One Stop Systems (OSS) is forecasting revenue growth of 15.1% per year, outpacing the US market’s projected 10.5% annual increase. Despite this robust top-line outlook, the company remains unprofitable and has experienced annual net losses rising at a steep 69.1% rate over the past five years, with no meaningful improvement in net profit margins. As a result, investors find themselves weighing the prospect of strong revenue expansion against ongoing challenges in profitability and a...
NasdaqGS:GLNG
NasdaqGS:GLNGOil and Gas

Golar LNG (GLNG): Profitability Forecasts Test Premium Valuation Narrative Ahead of Earnings

Golar LNG (GLNG) remains unprofitable, but the company has managed to shrink its losses by 4.6% per year over the past five years. Looking ahead, analysts project annual earnings growth of 51.12%, with expectations for profitability within the next three years. However, the company’s revenue growth forecast of 7.1% per year is behind the broader US market rate of 10.5%. See our full analysis for Golar LNG. The next step is to see how these headline numbers compare to the widely followed...
NasdaqCM:RDNW
NasdaqCM:RDNWSpecialty Retail

RideNow Group (RDNW): Losses Deepen at 34.3% Pace, Margin Stagnation Pressures Market Narrative

RideNow Group (RDNW) posted another challenging set of numbers, with losses deepening at a rapid 34.3% annual rate over the past five years. While revenue is projected to grow at just 4.4% per year, slower than the US market's 10.5% pace, the company's net profit margin has shown no improvement over the last year and there is no indication of high-quality past earnings. Despite the stock trading at a Price-To-Sales ratio of 0.1x, which is well below industry and peer averages, the persistence...
NYSE:BUR
NYSE:BURDiversified Financial

Burford Capital (BUR) Net Margin Jumps to 54.6%, Reinforcing Bullish Growth Narratives

Burford Capital (NYSE:BUR) is expected to deliver standout growth this year, with revenue forecast to rise 17.6% annually and earnings projected to climb 28.1% each year, both well ahead of the broader US market averages. The company’s net profit margin has increased to 54.6% from last year’s 47.2%, supported by a strong five-year earnings growth rate of 37.7%. Trading at a Price-to-Earnings ratio of 8.6x, which is well below industry and peer averages, and currently priced at $9.47 versus an...
NasdaqGS:EGHT
NasdaqGS:EGHTSoftware

8x8 (EGHT): Loss Reduction Continues, but Persistent Unprofitability Challenges Value Narrative

8x8 (EGHT) remains unprofitable, but over the past five years, the company has steadily reduced its losses by 34.4% per year. Its valuation stands out in the crowded software space, trading at a Price-To-Sales Ratio of just 0.4x. This figure is significantly below both the peer average of 15.9x and the US software industry average of 5.1x. While this low multiple may attract value-oriented investors, the share price has displayed notable volatility recently, and the lack of accelerating...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Fortrea Holdings (FTRE) Losses Deepen 52.8% Annually, Undervaluation Sparks Value Debate

Fortrea Holdings (FTRE) remains unprofitable, with losses accelerating at a 52.8% annual rate over the past five years. Looking ahead, analysts expect the company to stay in the red for at least three more years, while revenue growth is projected at just 2.4% per year, lagging the US market’s 10.5%. Despite trading at a Price-to-Sales Ratio of 0.4x, which is well below industry and peer averages, the current share price of $11.95 sits significantly under the estimated fair value of $18.73...
NasdaqGS:BATR.K
NasdaqGS:BATR.KEntertainment

Atlanta Braves Holdings (BATR.K): Loss Reduction Outpaces Expectations But Revenue Growth Lags Market Narrative

Atlanta Braves Holdings (BATR.K) remains unprofitable but has managed to reduce its losses by 6.9% per year over the past five years. With earnings projected to grow at 61.05% annually and the turning point to profitability anticipated within three years, ongoing loss reduction and expected profit growth are now the key points for investors keeping an eye on the company's earnings trajectory. See our full analysis for Atlanta Braves Holdings. Next up, we will stack these headline results...
NasdaqGS:RXRX
NasdaqGS:RXRXBiotechs

Recursion Pharmaceuticals (RXRX): Five-Year Loss Acceleration Challenges Bulls Despite 30.1% Revenue Growth Forecast

Recursion Pharmaceuticals (RXRX) remains firmly in the red, with losses increasing at an average rate of 35.2% per year over the past five years and no improvement in net profit margin. Despite this, revenue is forecast to accelerate at an impressive 30.1% per year, outpacing the broader US market’s projected 10.5% annual growth. Investors are weighing strong top-line growth expectations against a persistent track record of operating losses, a premium price-to-sales ratio of 33.6x, and a...
NYSE:LMND
NYSE:LMNDInsurance

Lemonade (LMND) Revenue Forecast Outpaces Market, Challenging Profitability and Valuation Narratives

Lemonade (LMND) is forecast to grow revenue at 27.1% per year, outpacing the US market average of 10.5% per year. Still, the company remains unprofitable, with losses increasing at a rate of 5.7% per year over the past five years and profitability not expected within the next three years. While investors may be drawn to the rapid growth potential, ongoing losses and lack of near-term profitability are likely to weigh on sentiment. See our full analysis for Lemonade. Next up, we will see how...
NYSE:MEG
NYSE:MEGCommercial Services

Montrose Environmental Group (MEG): Losses Narrow, But Slower Revenue Growth Reinforces Market Skepticism

Montrose Environmental Group (MEG) is forecasting revenue growth of 5.5% per year, trailing the wider US market’s expected 10.5% pace. The company remains in the red, but it has trimmed annual losses by an average of 11.1% over the past five years. While profitability remains elusive, investors are weighing the steady narrowing of losses against slower sales expansion and a premium Price-To-Sales Ratio. See our full analysis for Montrose Environmental Group. Now, let’s see how these latest...
NYSE:ACEL
NYSE:ACELHospitality

Accel Entertainment (ACEL) Net Profit Margin Decline Challenges Bullish Narratives

Accel Entertainment (ACEL) reported a net profit margin of 2.8%, down from last year’s 4.1%. Despite achieving an impressive annualized earnings growth rate of 28.9% over the last five years, earnings turned negative in the most recent year, halting positive profit momentum. With revenue projected to grow at 3.8% per year and a price-to-earnings ratio of 24.3x, which is above the US Hospitality industry average, the numbers paint a more cautious outlook, especially given the stock trades...
NYSE:CRC
NYSE:CRCOil and Gas

California Resources (CRC) Profit Margins Jump to 18.3%, Reinforcing Bullish Turnaround Narratives

California Resources (CRC) posted eye-catching results this quarter, with net profit margins jumping to 18.3%, up from 7.2% a year ago. Earnings rebounded 305.5% year-over-year, a major turnaround from the company’s five-year average decline of -25.6% annually. The share price sits at $46.27, well below an analyst fair value estimate of $114.76. This signals that investors are weighing strong profitability against looming concerns over slower revenue growth and projected earnings...